Mixed mesodermal sarcoma of the ovary in a young patient

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 65, Issue 2, 1996, Pages 249-253

  Fowler, Jeffrey M ^a,b   Nathan, Lauren ^a   Nieberg, Roberta K ^a   Berek, Jonathan S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

Author keywords

Mixed mesodermal sarcoma; Ovarian malignancy; Treatment

Indexed keywords

CISPLATIN; ETOPOSIDE; IFOSFAMIDE; MESNA;

ADULT; AGE; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; MESODERM; OVARY CANCER; PRIORITY JOURNAL; SARCOMA;

EID: 0029881228     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/0301-2115(95)02343-7     Document Type: Article

References (15)

1. Suggs CL, Lee JL, Choi H, Lewis GC. Malignant mixed mesodermal tumors of the ovary. Am J Clin Oncol 1988; 11: 12-15.
2. Anderson B, Turner DA, Benda J. Ovarian sarcoma. Gynecol Oncol 1987; 26: 183-192.
3. Sahine A, Benda JA. An immunohistochemical study of primary ovarian sarcoma: an evaluation of nine tumors. Int J Gynecol Pathol 1988; 7: 268-279.
4. Carlson JA, Edwards C, Wharton JT, Gallagher HS, Delclos L, Rutledge F. Mixed mesodermal sarcoma of the ovary treatment with combination of radiation and chemotherapy. Cancer 1983; 52: 1473-1477.
5. Azoury RS, Woodruff JD. Primary ovarian sarcomas: reported 43 cases from the Emil Novak ovarian tumor registry. Obstet Gynecol 1971; 37: 9-941.
6. Dehner LP, Norris HJ, and Taylor HB. Carcinosarcomas and mixed mesodermal tumors of the ovary. Cancer 1971; 27: 207-216.
7. Morrow CP, d'Ablaing G, Brady LW, Blessing JA, Hershchyshyn MM. Clinical and pathologic study of 30 cases of malignant mixed müllerian epithelial and mesenchymal tumors: a gynecologic oncology group study. Gynecol Oncol 1984; 18: 278-292.
8. Hanjani P, Peterson SE, Lipton SE, Nolte JA. Malignant mixed mesodermal tumors and carcinosarcoma of the ovary: reported 8 cases and review of the literature. Obstet Gynecol Surv 1988; 38: 537-545.
9. Berek JS. Non-epithelial ovarian and tubal cancers. Berek JS, Hacker NF, editors. In: Practical gynecologic oncology. Baltimore: Williams and Wilkins, 1989; 365-390.
10. Czernobilsky B. Common epithelial tumor of the ovary. In: Kurman RJ, editor. Blaustein's pathology of the female genital tract. New York: Springer-Vaerlay, 1987; 560-607.
11. Walker A, Hightower J, Walker G, Horst M. Anticytokeratin immunoreactivity in uterine smooth muscle cells. Surg Pathol 1989; 2: 305-322.
12. Daveney K, Tavassoli F. Immunohistochemistry as a diagnostic aid in the interpretation of unusual mesenchymal tumors of the uterus. Mod Pathol 1991; 4: 225-231.
13. Wheelock J, Hancock K, Smith F. Cisplatinum, doxorubicin, and cyclophospharnide in the treatment of mixed mesodermal tumor of the ovary. Cancer Treat Rep 71, 1987; 1275-1276.
14. Sutton GP, Blessing JA, Rosenshine N, Photopulos G, Di Saia PJ. Phase II trial of Ifosfarnide and mesna in mixed mesodermal tumors of the uterus: a Gynecologic Oncology Group study. Am J Obstet Gynecol 1989; 161: 309-312.
15. Koham EI, Schwartz PE, Chamber JT, Peschal RE, Kapp DS, Merino M. Adjuvant therapy in mixed muüllerian tumors of the uterus. Gynecol Oncol 1986; 23: 212-221.